AzTrials
AzTrials

Postpartum DepressionNCT03763435

The Effects of Pregnancy Classes and Contributing Factors to Postpartum Depression

An observational study of Postpartum Depression and Sleep Disorder, run by Bartin State Hospital at 1 site in Turkey (Türkiye).

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

It is recommended by the American College of Obstetricians and Gynecologists' Committee on Obstetric Practice that all obstetricians screen each women for postpartum depression and anxiety with a validated instrument. Read more about this study

Who is it for?
Any age, women only
What is being tested?
Antenatal pregnancy classes
How many people
400 participants
Where
1 siteTurkey (Türkiye)
Study dates
7 Dec 2018to 15 Jul 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: All women who gave birth in Bartin State Hospital (the only one hospital in the city) after October 2018. for three months.

Who may be able to join

  • All women in the puerpera period (who gave consent)

Who cannot join

  • None.

Trial locations and contacts

1 site in 1 country.

Murat Yassa, MD contact

+905335106312

murat.yassa@gmail.com

Turkey (Türkiye)1 site, 1 recruiting
  • Bartin State Hospital

    Bartın

    Murat Yassa, MD

    Nahide YAZICI, Midwife

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: The Effects of Pregnancy Classes on Postpartum Depression and Contributing Factors to Postpartum Depression

It is recommended by the American College of Obstetricians and Gynecologists' Committee on Obstetric Practice that all obstetricians screen each women for postpartum depression and anxiety with a validated instrument. Although much effort is made, the contributing factors still lack in the literature due to its multi-factorial nature and complexity.

In addition, the effects of prenatal education classes remain understudied. Therefore, this study aims to demonstrate the prevalence, characteristics and contributing factors of the postpartum depression. In addition, the change in prevalence and characteristics of the postpartum depression among women who had prenatal classes and not will also be assessed.

Read the detailed description

Specific and validated instruments will be performed to women in their 8th week of postpartum period.

Those instruments are:

Edinburgh Postpartum Depression Scale (EPDS) Female genital self-image scale (FGSIS) Insomnia Severity Index (ISI) Breast-feeding efficacy scale short form (BSES-SF) Beck Depression Scale

Being tested
Antenatal pregnancy classes
Keywords
postpartum depression, sleep disorder, genital self-image, breast-feeding, prevalence
Medical subject headings
Depression, Postpartum, Sleep Wake Disorders, Breast Feeding

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Antenatal pregnancy classesBehavioural

    At least three comprehensive full-day educational program covering all the stages of pregnancy.

Study groups in NCT03763435
Study groupRoleWhat they receive
Antenatal Classes ReceivedWomen who are involved into at least 3 comprehensive session of Antenatal pregnancy classes (educational) during the prenatal period.
Receives: Behavioral: Antenatal pregnancy classes
Without educationGroups are not randomized for not to give rise to ethical problems in order to maximize the community health care. Only women who are not involved into the educational classes due to their inaccessibility related to their own conditions or wishes.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postpartum Depression

    Postpartum Depression scores will be measured by Edinburgh Postpartum Scale (EDPS). The EDPS was developed to identify women who may have postpartum depression. Each answer is given a score of 0 to 3 . The maximum score is 30. The EPDS is a 10-item questionnaire. Women are asked to answer each question in terms of the past seven days. A score is calculated by adding the individual items as indicated A score of more than 10 suggests minor or major depression may be present.

    Measured: Change between the 4th, 8th and 12th weeks of postpartum period

Secondary outcomes (4)
  1. Genital self-image

    Genital Self-image scores will be measured by Female Genital Self Image Scale (FGSIS). FGSIS measures the genital self-image of the participants.

    The seven-item FGSIS assesses women's feelings and beliefs about their own genitals using a 4-point response scale (strongly agree, agree, disagree, strongly disagree).

    Respondents'scores on each item were summed for a total sum score ranging from 7 to 28, with higher scores indicating more positive genital self-image.

    Measured: At 4th, 8th and 12th week of postpartum period

  2. sleep disorders

    Sleep problems will be measured by Insomnia Severity Index (ISI). The ISI is a 7-item self-report questionnaire assessing the nature, severity, and impact of insomnia. A 5-point Likert scale is used to rate each item (e.g., 0 = no problem; 4 = very severe problem), yielding a total score ranging from 0 to 28. The total score is interpreted as follows: absence of insomnia (0-7); sub-threshold insomnia (8-14); moderate insomnia (15-21); and severe insomnia (22-28).

    Measured: At 4th, 8th and 12th week of postpartum period

  3. breast-feeding

    Breast-feeding will be assessed by the Breastfeeding Self-Efficacy Scale - Short Form (BSES-SF). It is a 14 item self-report instrument developed to measure a mother's perceived ability to breastfeed her infant. It has a five-point Likert scale for rating from 1 ("not at all confident") to 5 ("always confident"). Items ratings will be summed to produce a total score from 14 to 70, with higher scores indicating higher confidence. The means score points will be used as the cut-off point between high and low scorers.

    Measured: At 4th, 8th and 12th week of postpartum period

  4. socio-economic-demographical features

    Social, economic and demographic features will be assessed by a structured non-validated data gathering form

    Measured: At 4th postpartum week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Dec 2018
  2. Study start7 Dec 2018
  3. Primary completion15 Jun 2019 (estimated)
  4. Study completion15 Jul 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
400 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03763435
Sponsor's protocol ID
Bartin2018-3
Status last verified
Apr 2019
First submitted
24 Nov 2018
Last updated
23 Apr 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Lanes A, Kuk JL, Tamim H. Prevalence and characteristics of postpartum depression symptomatology among Canadian women: a cross-sectional study. BMC Public Health. 2011 May 11;11:302. doi: 10.1186/1471-2458-11-302.

    PubMed 21569372

Questions about this trial

What is this clinical trial studying?

An observational study of Postpartum Depression and Sleep Disorder, run by Bartin State Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 23 Apr 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Murat Yassa, MD (+905335106312, murat.yassa@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postpartum Depression (time frame: Change between the 4th, 8th and 12th weeks of postpartum period). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03763435, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Apr 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in